Torrent`s Generics Deferasirox Receives Approval in US
05 Nov 2024 //
FDA
Mylan`s Generic Deferasirox Receives Approval in the U.S.
17 May 2024 //
FDA
Mylan`s Generic Deferasirox Receives Approval in the U.S.
03 May 2024 //
FDA
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Teva`s Generic Deferasirox Receives Approval in the U.S.
23 Sep 2022 //
FDA
Annora`s Generic Deferasirox Receives Approval in the U.S.
22 Sep 2022 //
FDA
Teva Pharma`s Generic Deferasirox Receives Approval in the US
19 Nov 2021 //
FDA
Celltrion`s Generics Deferasirox Receives Approval in US
30 May 2021 //
FDA
Annora Pharma`s Generic Deferasirox Receives Approval In US
18 May 2021 //
FDA
MSN`s Generic Deferasirox Receives Approval In US
23 Mar 2021 //
FDA
Alkem Lab Generic Deferasirox Receives Approval in US
18 Jul 2020 //
FDA
Alkem Lab Generic Deferasirox Receives Approval in US
08 Jul 2020 //
FDA
Cipla`s Generic Albuterol Sulfate Receive Approval in US
23 Jun 2020 //
FDA
Piramal Healthcare`s Generic Deferasirox Receives Approval in U.S
23 Jun 2020 //
FDA
MSN `s Generic Deferasirox Receives Tentative Approval In US
23 Jun 2020 //
FDA
Amneal Pharmaceuticals Generic Deferasirox Receives Approval in US
22 Jun 2020 //
FDA
Zydus Pharms`s Generic Deferasirox Receives Approval in US
22 Jun 2020 //
FDA
Sun Pharm`s Generic Deferasirox Receives Approval In Us
22 Jun 2020 //
FDA
Alembic Pharma`s Generic Deferasirox Receives Approval in U.S
22 Jun 2020 //
FDA
Zydus Cadila gets USFDA approval to market generic version of Deferasirox
16 Jun 2020 //
INDIATIMES
Alembic Pharma gets US FDA approval for generic Jadenu tablets
15 Jun 2020 //
PHARMABIZ
Zydus receives USFDA final approval for Deferasirox Tablets
15 Jun 2020 //
BUSINESS
Alembic Pharma hits 52-week high on final USFDA approval for Deferasirox tablets
15 Jun 2020 //
MONEYCONTROL
Cipla`s Generic Deferasirox Receive Approval in U.S
15 Feb 2020 //
FDA
Glenmark gets US FDA nod for tablet used to treat high levels of iron
08 Jan 2020 //
BUSINESS STANDARD
Glenmark gets US FDA nod for tablet used to treat high levels of iron
08 Jan 2020 //
BUSINESS STANDARD
Glenmark gets US FDA nod for tablet used to treat high levels of iron
07 Jan 2020 //
BUSINESS STANDARD
Glenmark Pharm`s Generic Deferasirox Receives Approval In Us
03 Jan 2020 //
FDA
Sun Pharm`s Generic Deferasirox Receives Approval In Us
01 Jan 2020 //
FDA
Amneal Pharmaceutical`s Generic Deferasirox Receives Approval in US
27 Dec 2019 //
FDA
Actavis Elizabeth’s Generic Deferasirox Receives Approval In US
17 Dec 2019 //
FDA
Dr Reddy`s launches chronic iron overload treatment tablets in US
10 Dec 2019 //
MONEY CONTROL
Dr. Reddy`s Launches Deferasirox Tablets for Oral Suspension in the U.S.
06 Dec 2019 //
BUSINESS WIRE
Alembic Pharmaceuticals`s Generic Deferasirox Receives Approval in U.S
26 Nov 2019 //
FDA
Alembic Pharma gets USFDA nod for generic iron overload treatment tablets
23 Nov 2019 //
MONEY CONTROL
Cadila Healthcare`s Generic Deferasirox Receives Approval in US
22 Nov 2019 //
FDA
Sun Pharma`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
MSN Laboratorie`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
Alembic Pharmaceuticals Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
Alkem`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
Bionpharma`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
MSN Laboratorie`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
MSN Laboratorie`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
Alembic Pharmaceutical`s Generic Deferasirox Receives Approval in US
21 Nov 2019 //
FDA
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Teva announces launch of generic version of EXJADE®
25 Mar 2019 //
BIOSPECTRUMASIA
Teva Announces Launch of a Generic EXJADE (deferasirox) Tablets
22 Mar 2019 //
BUSINESSWIRE
Zydus Pharms ` Generic Deferasirox Receives Tentative Approval in US
23 Nov 2018 //
FDA
Zydus receives US FDA tentative approval to market Exjade tablets
20 Nov 2018 //
PHARMABIZ
Bionpharma`s Generic Deferasirox Receives Tentative Approval in US
06 Sep 2018 //
FDA
FDA Confirms Paragraph IV Patent Challenge of Jadenu (Deferasirox) Tablets
27 Sep 2017 //
FDA
SMC OKs four new therapies for NHS use in Scotland
18 Jan 2017 //
PHARMATIMES
Novartis to pay $390 million in U.S. settlement over pharmacy kickbacks
21 Nov 2015 //
REUTERS
Diplomat to Dispense Novartis Drug, JADENU™
15 Apr 2015 //
DIPLOMAT
Novartis` Jadenu (Deferasirox) Approved in USA For Chronic Iron Overload
04 Apr 2015 //
NOVARTIS